Neurol. praxi. 2023;24(6):415-418 | DOI: 10.36290/neu.2023.036

Transcranial sonography in Parkinson's disease

prof. MUDr. David Školoudík, Ph.D., FESO, FEAN, Mgr. Jiří Kozel, Mgr. Patricie Michalčová
Centrum zdravotnického výzkumu, Lékařská fakulta, Ostravská univerzita, Ostrava

Transcranial sonography is one of the modalities of transcranial sonographic examination, which enables to visualize intracranial structures in ultrasound B Mode. Using this examination, it is possible to evaluate changes in echogenicity or dimensions of selected brain structures, e.g. substantia nigra, ncl. raphe, ncl. lentiformis, ncl. caudate, insula, mediotemporal lobe or ventricular system. Thanks to this, transcranial sonography can be used as an auxiliary examination in the diagnosis and differential diagnosis of neurodegenerative and other neurological and psychiatric diseases of the central nervous system. A typical finding in Parkinson's disease is a asymmetric hyperechogenic substantia nigra. Since this sign can be detected many decades before the development of motor symptoms of Parkinson's disease itself, this examination can also be used to determine the risk of developing the disease, especially in combination with other tests.

Keywords: transkraniální sonografie, ultrazvuk, Parkinsonova nemoc, substantia nigra, neurodegenerativní onemocnění.

Received: May 28, 2023; Revised: May 28, 2023; Accepted: May 28, 2023; Prepublished online: May 28, 2023; Published: December 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Školoudík D, Kozel J, Michalčová P. Transcranial sonography in Parkinson's disease. Neurol. praxi. 2023;24(6):415-418. doi: 10.36290/neu.2023.036.
Download citation

References

  1. Bártová P, Školoudík D, Bar M, et al. Transcranial sonography in movement disorders. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152(2):251-8. doi: 10.5507/bp.2008.039. Go to original source... Go to PubMed...
  2. Becker G, Seufert J, Bogdahn U, et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color­‑coded real­‑time sonography. Neurology. 1995;45(1):182-4. doi: 10.1212/wnl.45. 1. 182. Go to original source...
  3. Becker G, Struck M, Bogdahn U, Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res. 1994;55(2):75-84. doi: 10.1016/0925-4927(94)90002-7. Go to original source... Go to PubMed...
  4. Becker G, Winkler J, Bogdahn U. Die transkranielle farbkodierte Real­‑Time­‑Sonographie des Erwachsenen. Teil 2: Zerebrale Blutungen und Tumoren [Transcranial color­‑coded real time sonography in adults. Part 2: Cerebral hemorrhage and tumors]. Ultraschall Med. 1991;12(5):211-7. doi: 10.1055/s-2007-1005932. Go to original source... Go to PubMed...
  5. Behnke S, Runkel A, Kassar HA, et al. Long­‑term course of substantia nigra hyperechogenicity in Parkinson's disease. Mov Disord. 2013;28(4):455-9. doi: 10.1002/mds.25193. Go to original source... Go to PubMed...
  6. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008;7(11):1044-55. doi: 10.1016/S1474-4422(08)70239-4. Go to original source... Go to PubMed...
  7. Bor­‑Seng­‑Shu E, Paschoal FM, Almeida KJ, et al. Transcranial brain sonography for Parkinsonian syndromes. J Neurosurg Sci. 2019;63(4):441-449. doi: 10.23736/S0390-5616. 19. 04696-4. Go to original source...
  8. Heim B, Peball M, Hammermeister J, et al. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta­‑Analysis. J Parkinsons, DiS. 2022;12(4):1115-1123. doi: 10.3233/JPD-213012. Go to original source... Go to PubMed...
  9. Heinzel S, Berg D, Gasser T, et al.; MDS Task Force on the Definition of Parkinson's Disease. Update of the MDS re­search criteria for prodromal Parkinson's disease. Mov Disord. 2019;34(10):1464-1470. doi: 10.1002/mds.27802. Go to original source... Go to PubMed...
  10. Kozel J, Školoudík D, Ressner P, et al. Echogenicity of Brain Structures in Huntington's Disease Patients evaluated by Transcranial Sonography-Magnetic Resonance Fusion Imaging using Virtual Navigator and Digital Image Analysis. Ultraschall Med. 2023; in press. Go to original source... Go to PubMed...
  11. Mei YL, Yang J, Wu ZR, et al. Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta­‑Analysis. Parkinsons, DiS. 2021 30;2021:8891874. doi: 10.1155/2021/8891874. Go to original source... Go to PubMed...
  12. Mijajlovic MD, Tsivgoulis G, Sternic N. Transcranial brain parenchymal sonography in neurodegenerative and psychiatric diseases. J Ultrasound Med. 2014;33(12):2061-8. doi: 10.7863/ultra.33. 12. 2061. Go to original source...
  13. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591-601. doi: 10.1002/mds.26424. Go to original source... Go to PubMed...
  14. Ressner P, Školoudík D, Hlustík P, et al. Hyperechogenicity of the substantia nigra in Parkinson's disease. J Neuroimaging. 2007;17(2):164-7. doi: 10.1111/j.1552-6569.2007.00114.x. Go to original source... Go to PubMed...
  15. Školoudík D, Fadrná T, Bártová P, et al. Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol. 2007;33(9):1347-52. doi: 10.1016/j.ultrasmedbio.2007. 03. 013. Go to original source...
  16. Školoudík D, Jelínková M, Blahuta J, et al. Transcranial sonography of the substantia nigra: digital image analysis. AJNR Am J Neuroradiol. 2014;35(12):2273-8. doi: 10.3174/ajnr.A4049. Go to original source... Go to PubMed...
  17. Školoudík D, Mašková J, Dušek P, et al. Digitized Image Analysis of Insula Echogenicity Detected by TCS­‑MR Fusion Imaging in Wilson's and Early­‑Onset Parkinson's Diseases. Ultrasound Med Biol. 2020;46(3):842-848. doi: 10.1016/j.ultrasmedbio.2019. 12. 013. Go to original source...
  18. Školoudík D, Škoda O, Bar M, et al. Neurosonologie. Praha: Galen, 2003.
  19. Toomsoo T, Liepelt­‑Scarfone I, Berg D, et al. Effect of Age on Substantia Nigra Hyper­‑echogenicity in Parkinson's Disease Patients and Healthy Controls. Ultrasound Med Biol. 2019;45(1):122-128. doi: 10.1016/j.ultrasmedbio.2018. 09. 018. Go to original source...
  20. Walter U, Školoudík D. Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med. 2014;35(4):322-31. doi: 10.1055/s-0033-1356415. Go to original source... Go to PubMed...
  21. Yilmaz R, Berg D. Transcranial B­‑Mode Sonography in Movement Disorders. Int Rev Neurobiol. 2018;143:179-212. doi: 10.1016/bs.irn.2018. 10. 008. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.